LOGIN
Pediatric cerebral palsy: AbobotulinumtoxinA safe + efficacious in equinus foot deformity
July 2016
Pediatric cerebral palsy: AbobotulinumtoxinA safe + efficacious in equinus foot deformity
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial
Pediatrics. 2016 Feb;137(2):1-9Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
241 pediatric patients (aged 2-17 years), with spasticity associated with cerebral palsy and dynamic equinus foot deformity, were randomized into three groups receiving either placebo treatment, 10 or 15U/kg/leg doses of botulinum neurotoxin type-A (BoNT-A) formulation (abobotulinumtoxinA). The purpose of this study was to assess the safety and efficacy of BoNT-A injections, in the gastrocnemius a...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.